CLINICAL_TRIALS
trial_result
· 2025-07-17
Clinical Trial Update: Rimegepant in Moderate Plaque-type Psoriasis [Phase 2]
Summary
Phase 2 study of rimegepant for moderate plaque-type psoriasis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-17